SlideShare ist ein Scribd-Unternehmen logo
1 von 119
3/2/2011 Case-control studies 1
Study designs: Case-control studies
Victor J. Schoenbach, PhD home page
Department of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
www.unc.edu/epid600/
Principles of Epidemiology for Public Health (EPID600)
10/7/2008 Case-control studies 2
From my uncle
Are you the weakest link?
Below are four (4) questions.
You have to answer them instantly.
You can't take your time, answer all of them
immediately. OK?
Let's find out just how clever you really are.
Ready?
10/7/2008 Case-control studies 3
Question 1
You are participating in a race.
You overtake the second person.
Question: What position are you in?
10/7/2008 Case-control studies 4
Question 1 – answer
If you answer that you are first, then you
are absolutely wrong!
Answer: If you overtake the second
person and you take his place, you are
second!
10/7/2008 Case-control studies 5
On to question 2
Try not to screw up on the next
question.
To answer the second question, don't
take as much time as you took for the
first question.
10/7/2008 Case-control studies 6
Question 2
Question: If you overtake the last
person, then you are …?
10/7/2008 Case-control studies 7
Question 2 – answer
Answer: If you answered that you are
second to last, then you are wrong again.
Tell me, how can you overtake the LAST
person?! …?
You're not very good at this are you?
10/7/2008 Case-control studies 8
On to question 3
The third question is very tricky math!
Note: This must be done in your head
only.
Do NOT use paper and pencil or a
calculator.
Try it.
10/7/2008 Case-control studies 9
Question 3 – what is the total?
Take 1000 and add 40 to it.
Now add another 1000.
Now add 30.
Add another 1000.
Now add 20.
Now add another 1000.
Now add 10.
10/7/2008 Case-control studies 10
Question 3 – answer
Did you get 5,000? The correct answer
is actually 4,100.
Don't believe it? Check with your
calculator!
10/7/2008 Case-control studies 11
On to question 4
Today is definitely not your day.
Maybe you will get the last question
right?
10/7/2008 Case-control studies 12
Question 4
Mary's father has five daughters: 1. Nana,
2. Nene, 3. Nini, 4. Nono.
Question: What is the name of the fifth
daughter?
10/7/2008 Case-control studies 13
Question 4 – answer
Answer: Nunu? NO! Of course not. Her
name is Mary. Read again.
(“Mary's father has five daughters.…”)
You ARE the WEAKEST LINK!!!!!! Good-
bye!!!
(With Love, Your Uncle)
10/7/2008 Case-control studies 14
Plan for this lecture
• Confidence intervals and significance tests (read only)
• Incidence density and cumulative incidence (brief)
• Attributable risk (brief)
• Theoretical overview of case-control studies as a
complement to the traditional perspective
10/7/2008 Case-control studies 15
Confidence intervals & significance tests
• Everything you’ve been told so far about
confidence intervals and statistical
significance is probably misleading,
including this statement.
• I am not licensed to teach statistics, so
what I say on this topic mustn’t leave this
room!
10/7/2008 Case-control studies 16
Confidence intervals
• “a plausible range of values for the unknown
population parameter”
Michael Oakes, Statistical inference, p.52
• Exact interpretation is problematic
• We are more confident that a 95% interval
covers the parameter than a 90% interval,
but the 95% interval is wider (provides a less
precise estimate)
10/7/2008 Case-control studies 17
Significance tests
“It might be argued that the significance test, if
properly understood, does no harm. This is,
perhaps, fair comment, but anyone who
appreciates the force of the case presented in
this chapter will realize that equally, it does very
little good.”
Michael Oakes, Statistical inference, p.72
10/7/2008 Case-control studies 18
Incidence rate and incidence proportion
[incidence density and cumulative incidence]
10/7/2008 Case-control studies 19
IR (ID) and IP in a closed cohort
} CI
}1 – CI
T0 T1
10/7/2008 Case-control studies 20
Attributable risk
10/7/2008 Case-control studies 21
Attributable risk
Assume that we know a causal factor for a disease.
Conceptually, the “attributable risk” for that factor is:
1. difference in risk or incidence between exposed and
unexposed people or
2. difference in risk or incidence between total
population and unexposed people
10/7/2008 Case-control studies 22
Attributable risk
Attributable risk can be presented as:
1. an “absolute” number, e.g., “80,000, or 20 per 100
cases/year of stroke are attributable to smoking”
2. a “relative” number, e.g., “20% of stroke cases are
attributable to smoking”.
(analogy: a wage increase in a part-time job: $ increase,
% increase in wage, % increase in income)
10/7/2008 Case-control studies 23
For relative measures, think of % of cases
R1
R1 – R0 =
"Attributable
R0
R0 n0 R0 n1
risk"
n0 n1
People
Incidencerateorproportions
10/7/2008 Case-control studies 24
For relative measures, think of % of cases
R1
R1 – R0 =
"Attributable
R0
R0 n0 R0 n1
risk"
n0 n1
Substitute
population
Caseload
10/7/2008 Case-control studies 25
For relative measures, think of % of cases
R1
R1 – R0 =
"Attributable
R0
R0 n0 R0 n1
risk"
n0 n1
Caseload
10/7/2008 Case-control studies 26
Case-control studies
10/8/2001 Case-control studies 27
Case-control studies
• Traditional view: compare
- people who get the disease
- people who do not get the disease
• “Controls” a misnomer, derived from faulty
analogy to controls in experiment
• Modern conceptualization: controls are a
“window” into the “study base”
10/7/2008 Case-control studies 28
Case-control studies
Cases Controls
10/7/2008 Case-control studies 29
Population at risk (N=200)








10/7/2008 Case-control studies 30








O
Week 1
O
10/7/2008 Case-control studies 31








O
Week 2
O
O
O
O
10/7/2008 Case-control studies 32








O
OO
Week 3
O
O
O
O
10/7/2008 Case-control studies 33
Incidence rate
(“incidence density”)
Number of new cases
IR = –––––––––––––––––––
Population time
6/23/2002 Case-control studies 34
Incidence rate
(“incidence density”)
Number of new cases 7
IR = ––––––––––––––––––– = ––––––
Population time ?
6/23/2002 Case-control studies 35
Incidence rate
(“incidence density”)
Population time at risk:
200 people for 3 weeks = 600 person-wks
But 2 people became cases in 1st week
3 people became cases in 2nd week
2 people became cases in 3rd week
Only 193 people at risk for 3 weeks
6/23/2002 Case-control studies 36
Incidence rate
(“incidence density”)
Assume that:
2 people who became cases in 1st week were
at risk for 0.5 weeks each = 2 @ 0.5 = 1.0
3 people who became cases in 2nd week
were at risk for 1.5 weeks each = 3 @ 1.5 = 4.5
2 people who became cases in 3rd week
were at risk for 2.5 weeks each = 2 @ 2.5 = 5.0
6/23/2002 Case-control studies 37
Incidence rate
(“incidence density”)
Total population-time =
Cases occuring during week 1: 1.0 p-w
Cases occuring during week 2: 4.5 p-w
Cases occuring during week 3: 5.0 p-w
Non-cases: 193 x 3 = 579.0 p-w
589.5 p-w
6/23/2002 Case-control studies 38
Incidence rate
(“incidence density”)
7
IR = –––––– = 0.0119 cases / person-wk
589.5
average over 3 weeks
Number of new cases
IR = –––––––––––––––––––
Population time
3/2/2011 Case-control studies 39
Incidence proportion
(“cumulative incidence”)
Number of new cases
CI = –––––––––––––––––––
Population at risk
10/7/2008 Case-control studies 40
Incidence proportion
(“cumulative incidence”)
7
3-week CI = –––– = 0.035
200
Number of new cases
CI = –––––––––––––––––––
Population at risk
10/7/2008 Case-control studies 41
Can estimate incidence in people who
are “exposed”



O
Week 1
10/7/2008 Case-control studies 42
Can estimate incidence in people who
are “exposed”



O
Week 2
O
O
10/7/2008 Case-control studies 43
Can estimate incidence in people who
are “exposed”


O
Week 3
O
O
O
10/7/2008 Case-control studies 44
Can estimate incidence in people who
are “unexposed”





O
Week 1
10/7/2008 Case-control studies 45
Can estimate incidence in people who
are “unexposed”





O
Week 2
O
10/7/2008 Case-control studies 46
Can estimate incidence in people who
are “unexposed”





O
Week 3
O
O
10/7/2008 Case-control studies 47
Entire population, week 1



O





O
10/7/2008 Case-control studies 48
Entire population, week 2








O
O
O
O
O
10/7/2008 Case-control studies 49
Entire population, week 3








O
O
O
O
O
O
O
10/7/2008 Case-control studies 50
Incidence rate
(“incidence density”)
Number of new cases
IR = –––––––––––––––––––
Population time
10/7/2008 Case-control studies 51
Incidence rate
in exposed during three weeks
4 4
IR = –––––––––––––– = –––– = 0.018 / wk
74.5 + 73 + 71.5 219
Number of new cases
IR = –––––––––––––––––––
Population time
10/7/2008 Case-control studies 52
Incidence rate
in unexposed during three weeks
3 3
IR = –––––––––––––––––– = ––––– = 0.008 / wk
124.5 + 123.5 + 122.5 370.5
Number of new cases
IR = –––––––––––––––––––
Population time
10/7/2008 Case-control studies 53
Compare incidence rates in exposed
and unexposed
0
0.005
0.01
0.015
0.02
Exposed Unexposed
10/7/2008 Case-control studies 54
Difference between incidence rates in
exposed and unexposed
Incidence rate difference (IRD, IDD)
= (0.018 – 0.008) / wk
= 0.010 / week
How to interpret?
10/7/2008 Case-control studies 55
Difference in incidence rates
Incidence rate difference (IRD)
= (0.018 – 0.008) / wk
= 0.010 / week
“The rate in the exposed was 0.010 / week
greater than the rate in the unexposed.”
10/7/2008 Case-control studies 56
Relative difference in incidence rates
in exposed and unexposed
Relative incidence rate difference
0.018 – 0.008
= –––––––––––– = 2.25 – 1 = 1.25
0.008
How to interpret?
10/7/2008 Case-control studies 57
Relative difference in incidence rates
Relative incidence rate difference
0.018 – 0.008
= –––––––––––– = 2.25 – 1 = 1.25
0.008
“The rate in the exposed was 125% greater
than the rate in the unexposed.”
10/7/2008 Case-control studies 58
Ratio of incidence rates in exposed
and unexposed
0.018
Incidence rate ratio = –––––– = 2.25
(IRR, IDR) 0.008
How to interpret?
10/7/2008 Case-control studies 59
Ratio of incidence rates
0.018
Incidence rate ratio = –––––– = 2.25
(IRR, IDR) 0.008
“The rate in the exposed was 2.25 times the
rate in the unexposed.” [not “times greater”]
6/23/2002 Case-control studies 60
Estimating IRR and CIR with the
Odds Ratio
2/28/2006 Case-control studies 61
Odds
odds = probability / (1 – probability)
odds = risk / (1 – risk)
(most commonly)
Risk 0.010 0.050 0.100 0.20 0.80
Odds 0.010 0.053 0.111 0.25 4.00
1/29/2007 Case-control studies 62
For small probability, odds ≈ probability
0
0.2
0.4
0.6
0.8
1
1.2
0.01 0.02 0.03 0.04 0.05 0.06 0.07 0.08 0.09 0.10
Odds
Small p
1/29/2007 Case-control studies 63
Odds = probability / (1 – probability)
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
0.01
0.02
0.03
0.05
0.06
0.07
0.08
0.09
0.10
0.20
0.30
0.40
0.50
0.60Large
p
Odds
1/29/2007 Case-control studies 64
Odds
Any ratio of two natural numbers can be
regarded as an odds:
Exposed: 20
Unexposed: 30
Total: 50
Odds of exposure: 20/50 divided by 30/50
1/29/2007 Case-control studies 65
Incidence rate ratio
(a.k.a. “incidence density ratio”)
can be expressed as a ratio of odds
10/7/2008 Case-control studies 66
Incidence rate ratio
IR in exposed IR1
IRR = ––––––––––––––– = ––––
IR in unexposed IR0
1/29/2007 Case-control studies 67
Incidence rate ratio
IR1 Exposed cases / Exp PT
IRR = –––– = –––––––––––––––––––––––––
IR0 Unexposed cases / Unexp PT
(PT = “population time”)
10/7/2008 Case-control studies 68
Incidence density ratio is a ratio of
exposed to unexposed cases . . .
IR1 Exposed cases / Exp PT
IRR = –––– = ––––––––––––––––––––––––
IR0 Unexposed cases / Unexp PT
Exposed cases / Unexposed cases
= –––––––––––––––––––––––––––––
Exposed PT / Unexposed PT
10/7/2008 Case-control studies 69
. . . divided by a ratio of exposed to
unexposed population-time
IR1 Exposed cases / Exp PT
IRR = –––– = ––––––––––––––––––––––––
IR0 Unexposed cases / Unexp PT
Exposed cases / Unexposed cases
= ––––––––––––––––––––––––––––
Exposed PT / Unexposed PT
10/7/2008 Case-control studies 70
Ratio of exposed to unexposed cases
= “exposure odds” in cases
Exposed cases / Unexposed cases
IRR = –––––––––––––––––––––––––––––––
Exp Person-time / Unexp Person-time
“Exposure odds” in cases
= ––––––––––––––––––––––––––
“Exposure odds” in population
10/7/2008 Case-control studies 71
Ratio of exposed to unexposed
population-time = “exposure odds”
Exposed cases / Unexposed cases
IRR = ––––––––––––––––––––––––––––––––
Exp Person-time / Unexp Person-time
“Exposure odds” in cases
= –––––––––––––––––––––––––––
“Exposure odds” in population
10/7/2008 Case-control studies 72
Count exposed and unexposed cases








O
O
O
O
O
O
O
10/7/2008 Case-control studies 73
From before:
Exposed:
4 4
IR = –––––––––––––– = –––– = 0.018 / wk
74.5 + 73 + 71.5 219
Unexposed:
3 3
IR = –––––––––––––––––– = ––––– = 0.008 / wk
124.5 + 123.5 + 122.5 370.5
2/28/2006 Case-control studies 74
Exposure odds in cases
= Exposed cases / Unexposed cases
= (4/7) / (3/7) = 4 / 3
= 1.33
The exposure odds in cases are 1.33
10/7/2008 Case-control studies 75
From before:
Exposed:
4 4
ID = –––––––––––––– = –––– = 0.018 / wk
74.5 + 73 + 71.5 219
Unexposed:
3 3
ID = –––––––––––––––––– = ––––– = 0.008 / wk
124.5 + 123.5 + 122.5 370.5
10/7/2008 Case-control studies 76
Exposure odds in population-time
= Exp. person-time / Unexp. person-time
= (74.5 + 73 + 71.5) / (124.5 + 123.5 + 122.5 )
= 219 / 370.5
= 0.59
The exposure odds in population-time are 0.59
10/7/2008 Case-control studies 77
So incidence rate ratio can be
expressed as a ratio of odds
“Exposure odds” in cases
IRR = –––––––––––––––––––––––––
“Exposure odds” in population
1.33
= –––––– = 2.25 (same as earlier)
0.59
1/29/2007 Case-control studies 78








O
O
O
O
O
O
O
Can we estimate exposure odds in the
population by taking a sample?
1/29/2007 Case-control studies 79
Take sample of “risk set” –
“density controls” – week 1



O





O
10/7/2008 Case-control studies 80
Take sample of “risk set” –
“density controls” – week 2








O
O
O
O
O
2/28/2006 Case-control studies 81
Take sample of “risk set” –
“density controls” – week 3








O
O
O
O
O
O
O
10/7/2008 Case-control studies 82
Now estimate incidence rate ratio
using the “density controls”
IR1 Exposed cases / Unexposed cases IRR
= –––– = –––––––––––––––––––––––––––
IR0 Exposed PT / Unexposed PT
10/7/2008 Case-control studies 83
Estimating the population odds with
the odds in the control group
Exposed cases / Unexposed cases
IDR = –––––––––––––––––––––––––––––––
Exposed controls / Unexposed controls
We call this the “exposure odds ratio” (OR).
3/4/2002 Case-control studies 84
Exposure odds ratio = estimates
incidence rate ratio (a.k.a. IDR)
1.33 1.33
OR = ––––– = ––––– = 2.22
6 / 10 0.60
1/29/2007 Case-control studies 85
Odds ratio from a 2 x 2 table
Cases Controls
Exposed a b
Unexposed c d
a / c ad
Odds ratio = ––––– = –––
b / d bc
3/4/2002 Case-control studies 86
Odds ratio from a 2 x 2 table
Cases Controls
Exposed 4 6
Unexposed 3 10
4 / 3 (4) (10)
Odds ratio = –––––– = –––––––
6 / 10 (6) (3)
10/7/2008 Case-control studies 87
What about incidence proportion in a
cohort? (“cumulative incidence”)
Number of new cases
3-week CI = –––––––––––––––––––
Population at risk
10/7/2008 Case-control studies 88
Population at risk – baseline








10/7/2008 Case-control studies 89
Entire population, week 3








O
O
O
O
O
O
O
10/7/2008 Case-control studies 90
Cumulative incidence in exposed
Number of new exposed cases
3-week CI = –––––––––––––––––––––––––––
Exposed population at risk
4
3-week CI = –––– = 0.053
75
10/7/2008 Case-control studies 91
Cumulative incidence in unexposed
Number of new unexposed cases
3-week CI = ––––––––––––––––––––––––––––
Unexposed population at risk
3
3-week CI = –––– = 0.024
125
10/7/2008 Case-control studies 92
Compare incidence proportions in
exposed and unexposed
0
0.01
0.02
0.03
0.04
0.05
0.06
Exposed Unexposed
10/7/2008 Case-control studies 93
Difference in incidence proportions
between exposed and unexposed
3-wk cumulative incidence difference (CID)
= (0.053 – 0.024)
= 0.029
How to interpret?
10/7/2008 Case-control studies 94
Difference in incidence proportions
3-wk cumulative incidence difference (CID)
= (0.053 – 0.024)
= 0.029
“The 3-week cumulative incidence in the
exposed was 0.029 greater than in the
unexposed.”
10/7/2008 Case-control studies 95
Relative difference in incidence
proportions for exposed and unexposed
3-wk cumulative incidence relative difference
(0.053 – 0.024) 0.029
= –––––––––––––– = –––––– = 1.22
0.024 0.024
How to interpret?
10/7/2008 Case-control studies 96
Relative difference in incidence
proportions
3-wk cumulative incidence relative difference
(0.053 – 0.024) 0.029
= –––––––––––––– = –––––– = 1.22
0.024 0.024
“The 3-week CI in the exposed was 122%
greater than in the unexposed.”
1/29/2007 Case-control studies 97
Ratio of incidence proportions for
exposed and unexposed
3-week cumulative incidence ratio (CIR)
= (0.053 / 0.024) = 2.22
How to interpret?
10/7/2008 Case-control studies 98
Ratio of incidence proportions (“relative
risk”, “risk ratio”)
3-week cumulative incidence ratio (CIR)
= (0.053 / 0.024) = 2.22
“The 3-week CI in the exposed was 2.2 times
that in the unexposed.” [not “times greater
than”]
10/7/2008 Case-control studies 99
Ratio of incidence proportions, a.k.a.
cumulative incidence ratio
CI1 Exposed cases / Exp PAR
CIR = –––– = ––––––––––––––––––––––––––
CI0 Unexposed cases / Unexp PAR
10/7/2008 Case-control studies 100
Cumulative incidence ratio can also be
expressed as a ratio of odds of
exposure in cases divided by . . .
CI1 Exposed cases / Exp PAR
CIR = –––– = ––––––––––––––––––––––––––
CI0 Unexposed cases / Unexp PAR
Exposed cases / Unexposed cases
= –––––––––––––––––––––––––––––
Exp PAR / Unexp PAR
10/7/2008 Case-control studies 101
. . . an odds of exposure in the
population at risk (PAR)
CI1 Exposed cases / Exp PAR
CIR = –––– = ––––––––––––––––––––––––––
CI0 Unexposed cases / Unexp PAR
Exposed cases / Unexposed cases
= –––––––––––––––––––––––––––––
Exp PAR / Unexp PAR
10/7/2008 Case-control studies 102
So cumulative incidence ratio is also
an odds ratio
CI1 Exposed cases / Unexposed cases
CIR = ––– = –––––––––––––––––––––––––––
CI0 Exp PAR / Unexp PAR
Exposure odds in cases
= –––––––––––––––––––––––––––––––
Exposure odds in population at risk
10/7/2008 Case-control studies 103
Exposure odds in cases
= Exposed cases / Unexposed cases
= 4 / 3
= 1.33
(same as for incidence density ratio)
10/7/2008 Case-control studies 104
Population at risk
(before cases occur)








1/29/2007 Case-control studies 105
Exposure odds in population at risk
(before cases occur)
= Exposed PAR / Unexposed PAR
= 75 / 125
= 0.60
(slightly different from odds of exposure for
person-time)
10/7/2008 Case-control studies 106
So cumulative incidence ratio is also
an odds ratio
CI1 Exposure odds in cases
CIR = –––– = ––––––––––––––––––––––––
CI0 Exposure odds in pop. at risk
1.33
3-week CIR = ––––– = 2.22
0.60
10/7/2008 Case-control studies 107
So if can estimate exposure odds in
PAR, may not need to analyze entire
cohort
“Case-cohort” or “case-base” design
Can be very advantageous if, for example,
one wants to analyze specimens stored at
baseline.
10/7/2008 Case-control studies 108
Sample from population at risk (before
cases occur)








10/7/2008 Case-control studies 109
Exposure odds in controls
= Exp. controls / Unexp. controls
= 6 / 10
= 0.60
(expected value for the estimated odds)
10/7/2008 Case-control studies 110
Cumulative incidence ratio
CI1 Exposed odds in cases
CIR = ––– = –––––––––––––––––––––––
CI0 Exposure odds in population
1.33
3-wk CIR = exposure OR = ––––– = 2.22
0.6
10/7/2008 Case-control studies 111
What if cannot sample
population at risk?
• Draw controls from noncases at end of
follow-up period
10/7/2008 Case-control studies 112
Non-cases at end of follow-up








O
O
O
O
O
O
O
71
122
10/7/2008 Case-control studies 113
Exposure odds in population at risk (after
cases occur)
= Exposed noncases / Unexp. noncases
= 71 / 122
= 0.58
(slightly different from ratio of
person-time and ratio of population at risk)
10/7/2008 Case-control studies 114
Odds ratio
Exposed odds in cases
OR = ––––––––––––––––––––––––
Exposure odds in population
1.33
= ––––– = 2.29
0.58
(slightly larger than CIR)
1/29/2007 Case-control studies 115
Draw controls from noncases








O
O
O
O
O
O
O
5
9
10/7/2008 Case-control studies 116
Exposure odds in
“cumulative” controls
= Exposed noncases / Unexp. noncases
= 5 / 9
(about) = 0.58
(Note: 5/9=0.555, but a larger “sample”
would produce 0.58)
10/7/2008 Case-control studies 117
Odds ratio
Exposed odds in cases
OR = ––––––––––––––––––––––––
Exposure odds in population
1.33
= ––––– = 2.29
0.58
(slightly larger than CIR)
1/29/2007 Case-control studies 118
Case-control design is an efficient
sampling technique
• Much more efficient, especially for rare
outcomes
• Validity depends upon whether controls
provide a clear view of population from
which cases arise
• Susceptible to various sources of bias
10/7/2008 Case-control studies 119
New Software for Psychics
“Notice to user: By breaking the seal of
this envelope, you accept the terms of
the enclosed license agreement.”
– Adobe Font Pack for Windows
Source: Willmott, Don, Abort, Retry, Fail? PC Magazine,
June 14, 1994, 482.

Weitere ähnliche Inhalte

Was ist angesagt?

Case control & other study designs-i-dr.wah
Case control & other study designs-i-dr.wahCase control & other study designs-i-dr.wah
Case control & other study designs-i-dr.wahMmedsc Hahm
 
Case Control Study Design
Case Control Study DesignCase Control Study Design
Case Control Study Designanmolayaz
 
Case control study
Case control studyCase control study
Case control studyTimiresh Das
 
Case control studies
Case control studiesCase control studies
Case control studiesBruno Mmassy
 
SAMS EBM Online Course: Observational Study Designs
SAMS EBM Online Course: Observational Study DesignsSAMS EBM Online Course: Observational Study Designs
SAMS EBM Online Course: Observational Study DesignsAhmad Al-Moujahed
 
Case control study - Part 2
Case control study - Part 2Case control study - Part 2
Case control study - Part 2Rizwan S A
 
Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1Rizwan S A
 
Bias and confounding in Cohort and case control study
Bias and confounding in Cohort and case control studyBias and confounding in Cohort and case control study
Bias and confounding in Cohort and case control studyIkram Ullah
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designsIsmail Qamar
 
Confounding and interaction seminar
Confounding and interaction seminarConfounding and interaction seminar
Confounding and interaction seminararundhati garud
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiologySubraham Pany
 
Bias, confounding and causality in p'coepidemiological research
Bias, confounding and causality in p'coepidemiological researchBias, confounding and causality in p'coepidemiological research
Bias, confounding and causality in p'coepidemiological researchsamthamby79
 
Analytical study designs case control study
Analytical study designs case control studyAnalytical study designs case control study
Analytical study designs case control studyjarati
 
Analytical epidemiology
Analytical  epidemiologyAnalytical  epidemiology
Analytical epidemiologyb_bhushan
 

Was ist angesagt? (20)

Case control & other study designs-i-dr.wah
Case control & other study designs-i-dr.wahCase control & other study designs-i-dr.wah
Case control & other study designs-i-dr.wah
 
Case Study Control | Statistics
Case Study Control | StatisticsCase Study Control | Statistics
Case Study Control | Statistics
 
Case Control Study Design
Case Control Study DesignCase Control Study Design
Case Control Study Design
 
Case control study
Case control studyCase control study
Case control study
 
Epidemiological_Case_Control_Study_Design
Epidemiological_Case_Control_Study_DesignEpidemiological_Case_Control_Study_Design
Epidemiological_Case_Control_Study_Design
 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confounding
 
Case control studies
Case control studiesCase control studies
Case control studies
 
SAMS EBM Online Course: Observational Study Designs
SAMS EBM Online Course: Observational Study DesignsSAMS EBM Online Course: Observational Study Designs
SAMS EBM Online Course: Observational Study Designs
 
Case control study - Part 2
Case control study - Part 2Case control study - Part 2
Case control study - Part 2
 
Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1
 
Bias and confounding in Cohort and case control study
Bias and confounding in Cohort and case control studyBias and confounding in Cohort and case control study
Bias and confounding in Cohort and case control study
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
Confounding and interaction seminar
Confounding and interaction seminarConfounding and interaction seminar
Confounding and interaction seminar
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiology
 
Types of bias
Types of biasTypes of bias
Types of bias
 
Case control studies
Case control studies  Case control studies
Case control studies
 
Bias, confounding and causality in p'coepidemiological research
Bias, confounding and causality in p'coepidemiological researchBias, confounding and causality in p'coepidemiological research
Bias, confounding and causality in p'coepidemiological research
 
Analytical study designs case control study
Analytical study designs case control studyAnalytical study designs case control study
Analytical study designs case control study
 
Analytical epidemiology
Analytical  epidemiologyAnalytical  epidemiology
Analytical epidemiology
 
Cohort Study
Cohort Study Cohort Study
Cohort Study
 

Ähnlich wie 08 case control studies

In search of the lost loss function
In search of the lost loss function In search of the lost loss function
In search of the lost loss function Stephen Senn
 
NurseReview.Org - Research Notes NLE Examination
NurseReview.Org - Research Notes NLE ExaminationNurseReview.Org - Research Notes NLE Examination
NurseReview.Org - Research Notes NLE Examinationjben501
 
Scientific Triage: How to make strategic choices about prioritizing basic sci...
Scientific Triage: How to make strategic choices about prioritizing basic sci...Scientific Triage: How to make strategic choices about prioritizing basic sci...
Scientific Triage: How to make strategic choices about prioritizing basic sci...nfefferman
 
Introduction to-ebm-2010-03-1
Introduction to-ebm-2010-03-1Introduction to-ebm-2010-03-1
Introduction to-ebm-2010-03-1Nazia Peer
 
Behavioral Science and Social Sciences_280316013607.pdf
Behavioral Science and Social Sciences_280316013607.pdfBehavioral Science and Social Sciences_280316013607.pdf
Behavioral Science and Social Sciences_280316013607.pdfSumni Uchiha
 
Study-Designs-in-Epidemiology-2.pdf
Study-Designs-in-Epidemiology-2.pdfStudy-Designs-in-Epidemiology-2.pdf
Study-Designs-in-Epidemiology-2.pdfKelvinSoko
 
Different Approaches to Ethics Teaching
Different Approaches to Ethics TeachingDifferent Approaches to Ethics Teaching
Different Approaches to Ethics TeachingChris Willmott
 
Study design slides week 3
Study design slides week 3Study design slides week 3
Study design slides week 3stanbridge
 
Patient Voices Network Forum: Consumer Health 2.0 Handout
Patient Voices Network Forum: Consumer Health 2.0 HandoutPatient Voices Network Forum: Consumer Health 2.0 Handout
Patient Voices Network Forum: Consumer Health 2.0 HandoutDaniel Hooker
 
Introduction to research and developing research idea
Introduction to research and developing research ideaIntroduction to research and developing research idea
Introduction to research and developing research ideaKaimrc_Rss_Jd
 
Running Head FINAL PROJECT SCHOLARLY REFERENCES .docx
Running Head FINAL PROJECT SCHOLARLY REFERENCES                 .docxRunning Head FINAL PROJECT SCHOLARLY REFERENCES                 .docx
Running Head FINAL PROJECT SCHOLARLY REFERENCES .docxwlynn1
 
Question 1Using this 2 x 2 table, determine which of the following.pdf
Question 1Using this 2 x 2 table, determine which of the following.pdfQuestion 1Using this 2 x 2 table, determine which of the following.pdf
Question 1Using this 2 x 2 table, determine which of the following.pdfalamshoes001
 
Week 5 Primary, Secondary data and G
Week 5 Primary, Secondary data and GWeek 5 Primary, Secondary data and G
Week 5 Primary, Secondary data and GJamie Davies
 
Week 5 Data Types and Gottesman and Shields 1961
Week 5 Data Types and Gottesman and Shields 1961Week 5 Data Types and Gottesman and Shields 1961
Week 5 Data Types and Gottesman and Shields 1961Jamie Davies
 

Ähnlich wie 08 case control studies (20)

In search of the lost loss function
In search of the lost loss function In search of the lost loss function
In search of the lost loss function
 
NurseReview.Org - Research Notes NLE Examination
NurseReview.Org - Research Notes NLE ExaminationNurseReview.Org - Research Notes NLE Examination
NurseReview.Org - Research Notes NLE Examination
 
Scientific Triage: How to make strategic choices about prioritizing basic sci...
Scientific Triage: How to make strategic choices about prioritizing basic sci...Scientific Triage: How to make strategic choices about prioritizing basic sci...
Scientific Triage: How to make strategic choices about prioritizing basic sci...
 
Introduction to-ebm-2010-03-1
Introduction to-ebm-2010-03-1Introduction to-ebm-2010-03-1
Introduction to-ebm-2010-03-1
 
Module5_Study_Design.pptx
Module5_Study_Design.pptxModule5_Study_Design.pptx
Module5_Study_Design.pptx
 
Behavioral Science and Social Sciences_280316013607.pdf
Behavioral Science and Social Sciences_280316013607.pdfBehavioral Science and Social Sciences_280316013607.pdf
Behavioral Science and Social Sciences_280316013607.pdf
 
03 incidence preval
03 incidence preval03 incidence preval
03 incidence preval
 
Study-Designs-in-Epidemiology-2.pdf
Study-Designs-in-Epidemiology-2.pdfStudy-Designs-in-Epidemiology-2.pdf
Study-Designs-in-Epidemiology-2.pdf
 
Different Approaches to Ethics Teaching
Different Approaches to Ethics TeachingDifferent Approaches to Ethics Teaching
Different Approaches to Ethics Teaching
 
Sample size calculation
Sample size calculationSample size calculation
Sample size calculation
 
Research by MAGIC
Research by MAGICResearch by MAGIC
Research by MAGIC
 
Study design slides week 3
Study design slides week 3Study design slides week 3
Study design slides week 3
 
Patient Voices Network Forum: Consumer Health 2.0 Handout
Patient Voices Network Forum: Consumer Health 2.0 HandoutPatient Voices Network Forum: Consumer Health 2.0 Handout
Patient Voices Network Forum: Consumer Health 2.0 Handout
 
Introduction to research and developing research idea
Introduction to research and developing research ideaIntroduction to research and developing research idea
Introduction to research and developing research idea
 
HINZ Education Workshop: Evidence Based Practice
HINZ Education Workshop: Evidence Based PracticeHINZ Education Workshop: Evidence Based Practice
HINZ Education Workshop: Evidence Based Practice
 
Running Head FINAL PROJECT SCHOLARLY REFERENCES .docx
Running Head FINAL PROJECT SCHOLARLY REFERENCES                 .docxRunning Head FINAL PROJECT SCHOLARLY REFERENCES                 .docx
Running Head FINAL PROJECT SCHOLARLY REFERENCES .docx
 
2-4StudyDesign_slides.ppt
2-4StudyDesign_slides.ppt2-4StudyDesign_slides.ppt
2-4StudyDesign_slides.ppt
 
Question 1Using this 2 x 2 table, determine which of the following.pdf
Question 1Using this 2 x 2 table, determine which of the following.pdfQuestion 1Using this 2 x 2 table, determine which of the following.pdf
Question 1Using this 2 x 2 table, determine which of the following.pdf
 
Week 5 Primary, Secondary data and G
Week 5 Primary, Secondary data and GWeek 5 Primary, Secondary data and G
Week 5 Primary, Secondary data and G
 
Week 5 Data Types and Gottesman and Shields 1961
Week 5 Data Types and Gottesman and Shields 1961Week 5 Data Types and Gottesman and Shields 1961
Week 5 Data Types and Gottesman and Shields 1961
 

Mehr von Abdiwali Abdullahi Abdiwali

STATEMENT BY THE HUMANITARIAN COORDINATOR FOR SOMALIA, PHILIPPE LAZZARINI
STATEMENT BY THE HUMANITARIAN COORDINATOR FOR SOMALIA, PHILIPPE LAZZARINISTATEMENT BY THE HUMANITARIAN COORDINATOR FOR SOMALIA, PHILIPPE LAZZARINI
STATEMENT BY THE HUMANITARIAN COORDINATOR FOR SOMALIA, PHILIPPE LAZZARINIAbdiwali Abdullahi Abdiwali
 
Lecture Notes of Nutrition For Health Extension Workers
Lecture Notes of Nutrition For Health Extension WorkersLecture Notes of Nutrition For Health Extension Workers
Lecture Notes of Nutrition For Health Extension WorkersAbdiwali Abdullahi Abdiwali
 
WHO–recommended standards for surveillance of selected vaccine-preventable di...
WHO–recommended standards for surveillance of selected vaccine-preventable di...WHO–recommended standards for surveillance of selected vaccine-preventable di...
WHO–recommended standards for surveillance of selected vaccine-preventable di...Abdiwali Abdullahi Abdiwali
 
Indicators for assessing infant and young child feeding practices Part 1 Defi...
Indicators for assessing infant and young child feeding practices Part 1 Defi...Indicators for assessing infant and young child feeding practices Part 1 Defi...
Indicators for assessing infant and young child feeding practices Part 1 Defi...Abdiwali Abdullahi Abdiwali
 
POLICY MAKING PROCESS training policy influence appiah-kubi, 16 dec 2015
POLICY MAKING PROCESS training policy influence appiah-kubi, 16 dec 2015POLICY MAKING PROCESS training policy influence appiah-kubi, 16 dec 2015
POLICY MAKING PROCESS training policy influence appiah-kubi, 16 dec 2015Abdiwali Abdullahi Abdiwali
 

Mehr von Abdiwali Abdullahi Abdiwali (20)

Communicable disease control
Communicable disease controlCommunicable disease control
Communicable disease control
 
Vector control
Vector controlVector control
Vector control
 
Outbreak investigation steps
Outbreak investigation stepsOutbreak investigation steps
Outbreak investigation steps
 
STATEMENT BY THE HUMANITARIAN COORDINATOR FOR SOMALIA, PHILIPPE LAZZARINI
STATEMENT BY THE HUMANITARIAN COORDINATOR FOR SOMALIA, PHILIPPE LAZZARINISTATEMENT BY THE HUMANITARIAN COORDINATOR FOR SOMALIA, PHILIPPE LAZZARINI
STATEMENT BY THE HUMANITARIAN COORDINATOR FOR SOMALIA, PHILIPPE LAZZARINI
 
Basic introduction communicable
Basic introduction communicableBasic introduction communicable
Basic introduction communicable
 
PRIMARY HEALTH CARE
PRIMARY HEALTH CAREPRIMARY HEALTH CARE
PRIMARY HEALTH CARE
 
Lecture Notes of Nutrition For Health Extension Workers
Lecture Notes of Nutrition For Health Extension WorkersLecture Notes of Nutrition For Health Extension Workers
Lecture Notes of Nutrition For Health Extension Workers
 
HIV prevention-2020-road-map
HIV prevention-2020-road-mapHIV prevention-2020-road-map
HIV prevention-2020-road-map
 
Ethics in public health surveillance
Ethics in public health surveillanceEthics in public health surveillance
Ethics in public health surveillance
 
Health planing and management
Health planing and managementHealth planing and management
Health planing and management
 
WHO–recommended standards for surveillance of selected vaccine-preventable di...
WHO–recommended standards for surveillance of selected vaccine-preventable di...WHO–recommended standards for surveillance of selected vaccine-preventable di...
WHO–recommended standards for surveillance of selected vaccine-preventable di...
 
Expended program in Immunization
Expended program in ImmunizationExpended program in Immunization
Expended program in Immunization
 
Water & sanitation handbook
Water & sanitation handbookWater & sanitation handbook
Water & sanitation handbook
 
Somali phast step guide.
Somali phast step guide.Somali phast step guide.
Somali phast step guide.
 
Introduction to Health education
Introduction to Health educationIntroduction to Health education
Introduction to Health education
 
Indicators for assessing infant and young child feeding practices Part 1 Defi...
Indicators for assessing infant and young child feeding practices Part 1 Defi...Indicators for assessing infant and young child feeding practices Part 1 Defi...
Indicators for assessing infant and young child feeding practices Part 1 Defi...
 
POLICY MAKING PROCESS training policy influence appiah-kubi, 16 dec 2015
POLICY MAKING PROCESS training policy influence appiah-kubi, 16 dec 2015POLICY MAKING PROCESS training policy influence appiah-kubi, 16 dec 2015
POLICY MAKING PROCESS training policy influence appiah-kubi, 16 dec 2015
 
Case controlstudyi
Case controlstudyi  Case controlstudyi
Case controlstudyi
 
Assessmentof nutritional status
Assessmentof nutritional statusAssessmentof nutritional status
Assessmentof nutritional status
 
Ancylostomiasis
AncylostomiasisAncylostomiasis
Ancylostomiasis
 

Kürzlich hochgeladen

Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...indiancallgirl4rent
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiAlinaDevecerski
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsGfnyt
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeCall Girls Delhi
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...narwatsonia7
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...Dipal Arora
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...astropune
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
 
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋TANUJA PANDEY
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 

Kürzlich hochgeladen (20)

Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 9907093804 Top Class Call Girl Service Ava...
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
 
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
 

08 case control studies

  • 1. 3/2/2011 Case-control studies 1 Study designs: Case-control studies Victor J. Schoenbach, PhD home page Department of Epidemiology Gillings School of Global Public Health University of North Carolina at Chapel Hill www.unc.edu/epid600/ Principles of Epidemiology for Public Health (EPID600)
  • 2. 10/7/2008 Case-control studies 2 From my uncle Are you the weakest link? Below are four (4) questions. You have to answer them instantly. You can't take your time, answer all of them immediately. OK? Let's find out just how clever you really are. Ready?
  • 3. 10/7/2008 Case-control studies 3 Question 1 You are participating in a race. You overtake the second person. Question: What position are you in?
  • 4. 10/7/2008 Case-control studies 4 Question 1 – answer If you answer that you are first, then you are absolutely wrong! Answer: If you overtake the second person and you take his place, you are second!
  • 5. 10/7/2008 Case-control studies 5 On to question 2 Try not to screw up on the next question. To answer the second question, don't take as much time as you took for the first question.
  • 6. 10/7/2008 Case-control studies 6 Question 2 Question: If you overtake the last person, then you are …?
  • 7. 10/7/2008 Case-control studies 7 Question 2 – answer Answer: If you answered that you are second to last, then you are wrong again. Tell me, how can you overtake the LAST person?! …? You're not very good at this are you?
  • 8. 10/7/2008 Case-control studies 8 On to question 3 The third question is very tricky math! Note: This must be done in your head only. Do NOT use paper and pencil or a calculator. Try it.
  • 9. 10/7/2008 Case-control studies 9 Question 3 – what is the total? Take 1000 and add 40 to it. Now add another 1000. Now add 30. Add another 1000. Now add 20. Now add another 1000. Now add 10.
  • 10. 10/7/2008 Case-control studies 10 Question 3 – answer Did you get 5,000? The correct answer is actually 4,100. Don't believe it? Check with your calculator!
  • 11. 10/7/2008 Case-control studies 11 On to question 4 Today is definitely not your day. Maybe you will get the last question right?
  • 12. 10/7/2008 Case-control studies 12 Question 4 Mary's father has five daughters: 1. Nana, 2. Nene, 3. Nini, 4. Nono. Question: What is the name of the fifth daughter?
  • 13. 10/7/2008 Case-control studies 13 Question 4 – answer Answer: Nunu? NO! Of course not. Her name is Mary. Read again. (“Mary's father has five daughters.…”) You ARE the WEAKEST LINK!!!!!! Good- bye!!! (With Love, Your Uncle)
  • 14. 10/7/2008 Case-control studies 14 Plan for this lecture • Confidence intervals and significance tests (read only) • Incidence density and cumulative incidence (brief) • Attributable risk (brief) • Theoretical overview of case-control studies as a complement to the traditional perspective
  • 15. 10/7/2008 Case-control studies 15 Confidence intervals & significance tests • Everything you’ve been told so far about confidence intervals and statistical significance is probably misleading, including this statement. • I am not licensed to teach statistics, so what I say on this topic mustn’t leave this room!
  • 16. 10/7/2008 Case-control studies 16 Confidence intervals • “a plausible range of values for the unknown population parameter” Michael Oakes, Statistical inference, p.52 • Exact interpretation is problematic • We are more confident that a 95% interval covers the parameter than a 90% interval, but the 95% interval is wider (provides a less precise estimate)
  • 17. 10/7/2008 Case-control studies 17 Significance tests “It might be argued that the significance test, if properly understood, does no harm. This is, perhaps, fair comment, but anyone who appreciates the force of the case presented in this chapter will realize that equally, it does very little good.” Michael Oakes, Statistical inference, p.72
  • 18. 10/7/2008 Case-control studies 18 Incidence rate and incidence proportion [incidence density and cumulative incidence]
  • 19. 10/7/2008 Case-control studies 19 IR (ID) and IP in a closed cohort } CI }1 – CI T0 T1
  • 20. 10/7/2008 Case-control studies 20 Attributable risk
  • 21. 10/7/2008 Case-control studies 21 Attributable risk Assume that we know a causal factor for a disease. Conceptually, the “attributable risk” for that factor is: 1. difference in risk or incidence between exposed and unexposed people or 2. difference in risk or incidence between total population and unexposed people
  • 22. 10/7/2008 Case-control studies 22 Attributable risk Attributable risk can be presented as: 1. an “absolute” number, e.g., “80,000, or 20 per 100 cases/year of stroke are attributable to smoking” 2. a “relative” number, e.g., “20% of stroke cases are attributable to smoking”. (analogy: a wage increase in a part-time job: $ increase, % increase in wage, % increase in income)
  • 23. 10/7/2008 Case-control studies 23 For relative measures, think of % of cases R1 R1 – R0 = "Attributable R0 R0 n0 R0 n1 risk" n0 n1 People Incidencerateorproportions
  • 24. 10/7/2008 Case-control studies 24 For relative measures, think of % of cases R1 R1 – R0 = "Attributable R0 R0 n0 R0 n1 risk" n0 n1 Substitute population Caseload
  • 25. 10/7/2008 Case-control studies 25 For relative measures, think of % of cases R1 R1 – R0 = "Attributable R0 R0 n0 R0 n1 risk" n0 n1 Caseload
  • 26. 10/7/2008 Case-control studies 26 Case-control studies
  • 27. 10/8/2001 Case-control studies 27 Case-control studies • Traditional view: compare - people who get the disease - people who do not get the disease • “Controls” a misnomer, derived from faulty analogy to controls in experiment • Modern conceptualization: controls are a “window” into the “study base”
  • 28. 10/7/2008 Case-control studies 28 Case-control studies Cases Controls
  • 29. 10/7/2008 Case-control studies 29 Population at risk (N=200)        
  • 30. 10/7/2008 Case-control studies 30         O Week 1 O
  • 31. 10/7/2008 Case-control studies 31         O Week 2 O O O O
  • 32. 10/7/2008 Case-control studies 32         O OO Week 3 O O O O
  • 33. 10/7/2008 Case-control studies 33 Incidence rate (“incidence density”) Number of new cases IR = ––––––––––––––––––– Population time
  • 34. 6/23/2002 Case-control studies 34 Incidence rate (“incidence density”) Number of new cases 7 IR = ––––––––––––––––––– = –––––– Population time ?
  • 35. 6/23/2002 Case-control studies 35 Incidence rate (“incidence density”) Population time at risk: 200 people for 3 weeks = 600 person-wks But 2 people became cases in 1st week 3 people became cases in 2nd week 2 people became cases in 3rd week Only 193 people at risk for 3 weeks
  • 36. 6/23/2002 Case-control studies 36 Incidence rate (“incidence density”) Assume that: 2 people who became cases in 1st week were at risk for 0.5 weeks each = 2 @ 0.5 = 1.0 3 people who became cases in 2nd week were at risk for 1.5 weeks each = 3 @ 1.5 = 4.5 2 people who became cases in 3rd week were at risk for 2.5 weeks each = 2 @ 2.5 = 5.0
  • 37. 6/23/2002 Case-control studies 37 Incidence rate (“incidence density”) Total population-time = Cases occuring during week 1: 1.0 p-w Cases occuring during week 2: 4.5 p-w Cases occuring during week 3: 5.0 p-w Non-cases: 193 x 3 = 579.0 p-w 589.5 p-w
  • 38. 6/23/2002 Case-control studies 38 Incidence rate (“incidence density”) 7 IR = –––––– = 0.0119 cases / person-wk 589.5 average over 3 weeks Number of new cases IR = ––––––––––––––––––– Population time
  • 39. 3/2/2011 Case-control studies 39 Incidence proportion (“cumulative incidence”) Number of new cases CI = ––––––––––––––––––– Population at risk
  • 40. 10/7/2008 Case-control studies 40 Incidence proportion (“cumulative incidence”) 7 3-week CI = –––– = 0.035 200 Number of new cases CI = ––––––––––––––––––– Population at risk
  • 41. 10/7/2008 Case-control studies 41 Can estimate incidence in people who are “exposed”    O Week 1
  • 42. 10/7/2008 Case-control studies 42 Can estimate incidence in people who are “exposed”    O Week 2 O O
  • 43. 10/7/2008 Case-control studies 43 Can estimate incidence in people who are “exposed”   O Week 3 O O O
  • 44. 10/7/2008 Case-control studies 44 Can estimate incidence in people who are “unexposed”      O Week 1
  • 45. 10/7/2008 Case-control studies 45 Can estimate incidence in people who are “unexposed”      O Week 2 O
  • 46. 10/7/2008 Case-control studies 46 Can estimate incidence in people who are “unexposed”      O Week 3 O O
  • 47. 10/7/2008 Case-control studies 47 Entire population, week 1    O      O
  • 48. 10/7/2008 Case-control studies 48 Entire population, week 2         O O O O O
  • 49. 10/7/2008 Case-control studies 49 Entire population, week 3         O O O O O O O
  • 50. 10/7/2008 Case-control studies 50 Incidence rate (“incidence density”) Number of new cases IR = ––––––––––––––––––– Population time
  • 51. 10/7/2008 Case-control studies 51 Incidence rate in exposed during three weeks 4 4 IR = –––––––––––––– = –––– = 0.018 / wk 74.5 + 73 + 71.5 219 Number of new cases IR = ––––––––––––––––––– Population time
  • 52. 10/7/2008 Case-control studies 52 Incidence rate in unexposed during three weeks 3 3 IR = –––––––––––––––––– = ––––– = 0.008 / wk 124.5 + 123.5 + 122.5 370.5 Number of new cases IR = ––––––––––––––––––– Population time
  • 53. 10/7/2008 Case-control studies 53 Compare incidence rates in exposed and unexposed 0 0.005 0.01 0.015 0.02 Exposed Unexposed
  • 54. 10/7/2008 Case-control studies 54 Difference between incidence rates in exposed and unexposed Incidence rate difference (IRD, IDD) = (0.018 – 0.008) / wk = 0.010 / week How to interpret?
  • 55. 10/7/2008 Case-control studies 55 Difference in incidence rates Incidence rate difference (IRD) = (0.018 – 0.008) / wk = 0.010 / week “The rate in the exposed was 0.010 / week greater than the rate in the unexposed.”
  • 56. 10/7/2008 Case-control studies 56 Relative difference in incidence rates in exposed and unexposed Relative incidence rate difference 0.018 – 0.008 = –––––––––––– = 2.25 – 1 = 1.25 0.008 How to interpret?
  • 57. 10/7/2008 Case-control studies 57 Relative difference in incidence rates Relative incidence rate difference 0.018 – 0.008 = –––––––––––– = 2.25 – 1 = 1.25 0.008 “The rate in the exposed was 125% greater than the rate in the unexposed.”
  • 58. 10/7/2008 Case-control studies 58 Ratio of incidence rates in exposed and unexposed 0.018 Incidence rate ratio = –––––– = 2.25 (IRR, IDR) 0.008 How to interpret?
  • 59. 10/7/2008 Case-control studies 59 Ratio of incidence rates 0.018 Incidence rate ratio = –––––– = 2.25 (IRR, IDR) 0.008 “The rate in the exposed was 2.25 times the rate in the unexposed.” [not “times greater”]
  • 60. 6/23/2002 Case-control studies 60 Estimating IRR and CIR with the Odds Ratio
  • 61. 2/28/2006 Case-control studies 61 Odds odds = probability / (1 – probability) odds = risk / (1 – risk) (most commonly) Risk 0.010 0.050 0.100 0.20 0.80 Odds 0.010 0.053 0.111 0.25 4.00
  • 62. 1/29/2007 Case-control studies 62 For small probability, odds ≈ probability 0 0.2 0.4 0.6 0.8 1 1.2 0.01 0.02 0.03 0.04 0.05 0.06 0.07 0.08 0.09 0.10 Odds Small p
  • 63. 1/29/2007 Case-control studies 63 Odds = probability / (1 – probability) 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 0.01 0.02 0.03 0.05 0.06 0.07 0.08 0.09 0.10 0.20 0.30 0.40 0.50 0.60Large p Odds
  • 64. 1/29/2007 Case-control studies 64 Odds Any ratio of two natural numbers can be regarded as an odds: Exposed: 20 Unexposed: 30 Total: 50 Odds of exposure: 20/50 divided by 30/50
  • 65. 1/29/2007 Case-control studies 65 Incidence rate ratio (a.k.a. “incidence density ratio”) can be expressed as a ratio of odds
  • 66. 10/7/2008 Case-control studies 66 Incidence rate ratio IR in exposed IR1 IRR = ––––––––––––––– = –––– IR in unexposed IR0
  • 67. 1/29/2007 Case-control studies 67 Incidence rate ratio IR1 Exposed cases / Exp PT IRR = –––– = ––––––––––––––––––––––––– IR0 Unexposed cases / Unexp PT (PT = “population time”)
  • 68. 10/7/2008 Case-control studies 68 Incidence density ratio is a ratio of exposed to unexposed cases . . . IR1 Exposed cases / Exp PT IRR = –––– = –––––––––––––––––––––––– IR0 Unexposed cases / Unexp PT Exposed cases / Unexposed cases = ––––––––––––––––––––––––––––– Exposed PT / Unexposed PT
  • 69. 10/7/2008 Case-control studies 69 . . . divided by a ratio of exposed to unexposed population-time IR1 Exposed cases / Exp PT IRR = –––– = –––––––––––––––––––––––– IR0 Unexposed cases / Unexp PT Exposed cases / Unexposed cases = –––––––––––––––––––––––––––– Exposed PT / Unexposed PT
  • 70. 10/7/2008 Case-control studies 70 Ratio of exposed to unexposed cases = “exposure odds” in cases Exposed cases / Unexposed cases IRR = ––––––––––––––––––––––––––––––– Exp Person-time / Unexp Person-time “Exposure odds” in cases = –––––––––––––––––––––––––– “Exposure odds” in population
  • 71. 10/7/2008 Case-control studies 71 Ratio of exposed to unexposed population-time = “exposure odds” Exposed cases / Unexposed cases IRR = –––––––––––––––––––––––––––––––– Exp Person-time / Unexp Person-time “Exposure odds” in cases = ––––––––––––––––––––––––––– “Exposure odds” in population
  • 72. 10/7/2008 Case-control studies 72 Count exposed and unexposed cases         O O O O O O O
  • 73. 10/7/2008 Case-control studies 73 From before: Exposed: 4 4 IR = –––––––––––––– = –––– = 0.018 / wk 74.5 + 73 + 71.5 219 Unexposed: 3 3 IR = –––––––––––––––––– = ––––– = 0.008 / wk 124.5 + 123.5 + 122.5 370.5
  • 74. 2/28/2006 Case-control studies 74 Exposure odds in cases = Exposed cases / Unexposed cases = (4/7) / (3/7) = 4 / 3 = 1.33 The exposure odds in cases are 1.33
  • 75. 10/7/2008 Case-control studies 75 From before: Exposed: 4 4 ID = –––––––––––––– = –––– = 0.018 / wk 74.5 + 73 + 71.5 219 Unexposed: 3 3 ID = –––––––––––––––––– = ––––– = 0.008 / wk 124.5 + 123.5 + 122.5 370.5
  • 76. 10/7/2008 Case-control studies 76 Exposure odds in population-time = Exp. person-time / Unexp. person-time = (74.5 + 73 + 71.5) / (124.5 + 123.5 + 122.5 ) = 219 / 370.5 = 0.59 The exposure odds in population-time are 0.59
  • 77. 10/7/2008 Case-control studies 77 So incidence rate ratio can be expressed as a ratio of odds “Exposure odds” in cases IRR = ––––––––––––––––––––––––– “Exposure odds” in population 1.33 = –––––– = 2.25 (same as earlier) 0.59
  • 78. 1/29/2007 Case-control studies 78         O O O O O O O Can we estimate exposure odds in the population by taking a sample?
  • 79. 1/29/2007 Case-control studies 79 Take sample of “risk set” – “density controls” – week 1    O      O
  • 80. 10/7/2008 Case-control studies 80 Take sample of “risk set” – “density controls” – week 2         O O O O O
  • 81. 2/28/2006 Case-control studies 81 Take sample of “risk set” – “density controls” – week 3         O O O O O O O
  • 82. 10/7/2008 Case-control studies 82 Now estimate incidence rate ratio using the “density controls” IR1 Exposed cases / Unexposed cases IRR = –––– = ––––––––––––––––––––––––––– IR0 Exposed PT / Unexposed PT
  • 83. 10/7/2008 Case-control studies 83 Estimating the population odds with the odds in the control group Exposed cases / Unexposed cases IDR = ––––––––––––––––––––––––––––––– Exposed controls / Unexposed controls We call this the “exposure odds ratio” (OR).
  • 84. 3/4/2002 Case-control studies 84 Exposure odds ratio = estimates incidence rate ratio (a.k.a. IDR) 1.33 1.33 OR = ––––– = ––––– = 2.22 6 / 10 0.60
  • 85. 1/29/2007 Case-control studies 85 Odds ratio from a 2 x 2 table Cases Controls Exposed a b Unexposed c d a / c ad Odds ratio = ––––– = ––– b / d bc
  • 86. 3/4/2002 Case-control studies 86 Odds ratio from a 2 x 2 table Cases Controls Exposed 4 6 Unexposed 3 10 4 / 3 (4) (10) Odds ratio = –––––– = ––––––– 6 / 10 (6) (3)
  • 87. 10/7/2008 Case-control studies 87 What about incidence proportion in a cohort? (“cumulative incidence”) Number of new cases 3-week CI = ––––––––––––––––––– Population at risk
  • 88. 10/7/2008 Case-control studies 88 Population at risk – baseline        
  • 89. 10/7/2008 Case-control studies 89 Entire population, week 3         O O O O O O O
  • 90. 10/7/2008 Case-control studies 90 Cumulative incidence in exposed Number of new exposed cases 3-week CI = ––––––––––––––––––––––––––– Exposed population at risk 4 3-week CI = –––– = 0.053 75
  • 91. 10/7/2008 Case-control studies 91 Cumulative incidence in unexposed Number of new unexposed cases 3-week CI = –––––––––––––––––––––––––––– Unexposed population at risk 3 3-week CI = –––– = 0.024 125
  • 92. 10/7/2008 Case-control studies 92 Compare incidence proportions in exposed and unexposed 0 0.01 0.02 0.03 0.04 0.05 0.06 Exposed Unexposed
  • 93. 10/7/2008 Case-control studies 93 Difference in incidence proportions between exposed and unexposed 3-wk cumulative incidence difference (CID) = (0.053 – 0.024) = 0.029 How to interpret?
  • 94. 10/7/2008 Case-control studies 94 Difference in incidence proportions 3-wk cumulative incidence difference (CID) = (0.053 – 0.024) = 0.029 “The 3-week cumulative incidence in the exposed was 0.029 greater than in the unexposed.”
  • 95. 10/7/2008 Case-control studies 95 Relative difference in incidence proportions for exposed and unexposed 3-wk cumulative incidence relative difference (0.053 – 0.024) 0.029 = –––––––––––––– = –––––– = 1.22 0.024 0.024 How to interpret?
  • 96. 10/7/2008 Case-control studies 96 Relative difference in incidence proportions 3-wk cumulative incidence relative difference (0.053 – 0.024) 0.029 = –––––––––––––– = –––––– = 1.22 0.024 0.024 “The 3-week CI in the exposed was 122% greater than in the unexposed.”
  • 97. 1/29/2007 Case-control studies 97 Ratio of incidence proportions for exposed and unexposed 3-week cumulative incidence ratio (CIR) = (0.053 / 0.024) = 2.22 How to interpret?
  • 98. 10/7/2008 Case-control studies 98 Ratio of incidence proportions (“relative risk”, “risk ratio”) 3-week cumulative incidence ratio (CIR) = (0.053 / 0.024) = 2.22 “The 3-week CI in the exposed was 2.2 times that in the unexposed.” [not “times greater than”]
  • 99. 10/7/2008 Case-control studies 99 Ratio of incidence proportions, a.k.a. cumulative incidence ratio CI1 Exposed cases / Exp PAR CIR = –––– = –––––––––––––––––––––––––– CI0 Unexposed cases / Unexp PAR
  • 100. 10/7/2008 Case-control studies 100 Cumulative incidence ratio can also be expressed as a ratio of odds of exposure in cases divided by . . . CI1 Exposed cases / Exp PAR CIR = –––– = –––––––––––––––––––––––––– CI0 Unexposed cases / Unexp PAR Exposed cases / Unexposed cases = ––––––––––––––––––––––––––––– Exp PAR / Unexp PAR
  • 101. 10/7/2008 Case-control studies 101 . . . an odds of exposure in the population at risk (PAR) CI1 Exposed cases / Exp PAR CIR = –––– = –––––––––––––––––––––––––– CI0 Unexposed cases / Unexp PAR Exposed cases / Unexposed cases = ––––––––––––––––––––––––––––– Exp PAR / Unexp PAR
  • 102. 10/7/2008 Case-control studies 102 So cumulative incidence ratio is also an odds ratio CI1 Exposed cases / Unexposed cases CIR = ––– = ––––––––––––––––––––––––––– CI0 Exp PAR / Unexp PAR Exposure odds in cases = ––––––––––––––––––––––––––––––– Exposure odds in population at risk
  • 103. 10/7/2008 Case-control studies 103 Exposure odds in cases = Exposed cases / Unexposed cases = 4 / 3 = 1.33 (same as for incidence density ratio)
  • 104. 10/7/2008 Case-control studies 104 Population at risk (before cases occur)        
  • 105. 1/29/2007 Case-control studies 105 Exposure odds in population at risk (before cases occur) = Exposed PAR / Unexposed PAR = 75 / 125 = 0.60 (slightly different from odds of exposure for person-time)
  • 106. 10/7/2008 Case-control studies 106 So cumulative incidence ratio is also an odds ratio CI1 Exposure odds in cases CIR = –––– = –––––––––––––––––––––––– CI0 Exposure odds in pop. at risk 1.33 3-week CIR = ––––– = 2.22 0.60
  • 107. 10/7/2008 Case-control studies 107 So if can estimate exposure odds in PAR, may not need to analyze entire cohort “Case-cohort” or “case-base” design Can be very advantageous if, for example, one wants to analyze specimens stored at baseline.
  • 108. 10/7/2008 Case-control studies 108 Sample from population at risk (before cases occur)        
  • 109. 10/7/2008 Case-control studies 109 Exposure odds in controls = Exp. controls / Unexp. controls = 6 / 10 = 0.60 (expected value for the estimated odds)
  • 110. 10/7/2008 Case-control studies 110 Cumulative incidence ratio CI1 Exposed odds in cases CIR = ––– = ––––––––––––––––––––––– CI0 Exposure odds in population 1.33 3-wk CIR = exposure OR = ––––– = 2.22 0.6
  • 111. 10/7/2008 Case-control studies 111 What if cannot sample population at risk? • Draw controls from noncases at end of follow-up period
  • 112. 10/7/2008 Case-control studies 112 Non-cases at end of follow-up         O O O O O O O 71 122
  • 113. 10/7/2008 Case-control studies 113 Exposure odds in population at risk (after cases occur) = Exposed noncases / Unexp. noncases = 71 / 122 = 0.58 (slightly different from ratio of person-time and ratio of population at risk)
  • 114. 10/7/2008 Case-control studies 114 Odds ratio Exposed odds in cases OR = –––––––––––––––––––––––– Exposure odds in population 1.33 = ––––– = 2.29 0.58 (slightly larger than CIR)
  • 115. 1/29/2007 Case-control studies 115 Draw controls from noncases         O O O O O O O 5 9
  • 116. 10/7/2008 Case-control studies 116 Exposure odds in “cumulative” controls = Exposed noncases / Unexp. noncases = 5 / 9 (about) = 0.58 (Note: 5/9=0.555, but a larger “sample” would produce 0.58)
  • 117. 10/7/2008 Case-control studies 117 Odds ratio Exposed odds in cases OR = –––––––––––––––––––––––– Exposure odds in population 1.33 = ––––– = 2.29 0.58 (slightly larger than CIR)
  • 118. 1/29/2007 Case-control studies 118 Case-control design is an efficient sampling technique • Much more efficient, especially for rare outcomes • Validity depends upon whether controls provide a clear view of population from which cases arise • Susceptible to various sources of bias
  • 119. 10/7/2008 Case-control studies 119 New Software for Psychics “Notice to user: By breaking the seal of this envelope, you accept the terms of the enclosed license agreement.” – Adobe Font Pack for Windows Source: Willmott, Don, Abort, Retry, Fail? PC Magazine, June 14, 1994, 482.

Hinweis der Redaktion

  1. Amedauwa, Ya’-teh habeen, Bienvenidos, Ni-hau, Bagunara, Karibu, Aloha
  2. A few years ago I told my uncle that I was giving, so he decided to send me an “exam” to take. It went like this: Are you the weakest link? Below are four (4) questions. You have to answer them instantly. You can't take your time, answer all of them immediately. OK? Let's find out just how clever you really are. Ready?
  3. Question 1: You are participating in a race. You overtake the second person. Question: What position are you in?
  4. Question 1 – answer: If you answer that you are first, then you are absolutely wrong! Answer: If you overtake the second person and you take his place, you are second!
  5. On to question 2: Try not to screw up on the next question. (Remember, this was from my uncle.) To answer the second question, don't take as much time as you took for the first question.
  6. Question 2: Question: If you overtake the last person, then you are …?
  7. Question 2 – answer: Answer: If you answered that you are second to last, then you are wrong again. Tell me, how can you overtake the LAST person?! …? You're not very good at this are you?
  8. On to question 3: The third question is very tricky math! Note: This must be done in your head only. Do NOT use paper and pencil or a calculator. Try it.
  9. Question 3 – what is the total? Take 1000 and add 40 to it. Now add another 1000. Now add 30. Add another 1000. Now add 20. Now add another 1000. Now add 10.
  10. Question 2 – answer: Did you get 5,000? The correct answer is actually 4,100. Don't believe it? Check with your calculator!
  11. On to question 4: Today is definitely not your day. Maybe you will get the last question right?
  12. Question 4: Mary's father has five daughters: 1. Nana, 2. Nene, 3. Nini, 4. Nono. Question: What is the name of the fifth daughter?
  13. Question 4 – answer: Answer: Nunu? NO! Of course not. Her name is Mary. Read again. (“Mary's father has five daughters.…”) You ARE the WEAKEST LINK!!!!!! Good-bye!!! (With Love, Your Uncle)
  14. This lecture has material on four topics, but the emphasis is on the last one. The cohort studies module case study has a question on confidence intervals and statistical significance. The point of the question was to have you articulate your understanding or belief about what these concepts mean. I’ll read a few slides to illustrate that the matter is not as settled as you may think. Second, in response to some questions that have arisen, I’ll talk briefly about the relation between incidence density and cumulative incidence. Similarly, I’ll speak briefly about the concept of attributable risk. Finally I’ll spend most of the time providing a theoretical overview of case-control studies, as a complement to the traditional perspective. The understanding of case-control studies has evolved greatly over the past several decades, and many statements you will read in articles and textbooks reflect an earlier perspective that you want to be aware of but which is not as useful as the newer view.
  15. First, I have two basic cautions: Everything you’ve been told so far about confidence intervals and statistical significance is probably misleading, including this statement. And, I am not licensed to teach statistics, so what I say on this topic should not be disseminated!
  16. Confidence intervals: A confidence interval is “a plausible range of values for the unknown population parameter” Michael Oakes, Statistical inference, p.52 The exact interpretation of confidence intervals is problematic. I used to subscribe to STAT-L, the statistics e-mail discussion list. Someone sent in a question about the interpretation of a confidence interval, and the discussion went on for a week! However, we can at least say that we are more confident that a 95% interval covers the parameter than a 90% interval, but the 95% interval is wider (provides a less precise estimate)
  17. Significance tests: Although it may surprise you to hear this heresy, not everyone is enamored with tests of statistical significance: “It might be argued that the significance test, if properly understood, does no harm. This is, perhaps, fair comment, but anyone who appreciates the force of the case presented in this chapter will realize that equally, it does very little good.” Michael Oakes, Statistical inference, p.72
  18. Incidence rate and incidence proportion[incidence density and cumulative incidence] Now, a few quick thoughts on the relation between incidence rates and incidence proportions.
  19. As discussed in the lecture on incidence and prevalence, there are two measures of the occurrence of disease – incidence rate (sometimes called “incidence density”, ID) and incidence proportion (sometimes called “cumulative incidence”, CI). When we are driving a car, we may want to know how fast we have been travelling, i.e., a rate. We may also want to know how far we have come, a cumulative measure. Similarly with the occurrence of cases, we may want to know the pace or intensity of the occurrence of cases (a rate) or how much of a population has been affected (a cumulative measure). The former question (“how fast”) is addressed by incidence density; the latter question (“how far”) is addressed by cumulative incidence. Incidence density is the rate of occurrence of new cases. The graph on the slide portrays ID and CI of an incurable disease in a closed cohort in which everyone is susceptible at baseline (T0) and no one leaves. The broken line that looks something like a descending staircase shows the percentages of the population that remain susceptible to become cases. The downward slope of that staircase corresponds (conceptually) to the incidence rate; the higher the incidence rate, the more rapidly the line will descend. By the end of some interval of time, say by T1, a proportion of the population has developed the disease. That proportion is the cumulative incidence. So ID is the rate of occurrence of cases, and CI is the accumulation of cases. (Note that the mathematical relation is somewhat more complex, so ID does not correspond to the actual slope. For a constant ID, the curve is one of exponential decay, as for the decay of a radioactive substance.)
  20. Now a few quick thoughts on the concept of attributable risk.
  21. If we can assume that we know that a factor is a cause of a disease, then conceptually, the “attributable risk” for that factor is the amount of risk for which it is responsible, i.e., the risk that would not have existed had the factor not been present or, if the risk is reversible, the amount by which risk would be reduced if the factor were eliminated. Conceptually, we are comparing the risk we observe to the counterfactual situation of the same people at the same time but with a different exposure status. We can calculate attributable risk among those who are exposed to the factor or in the total population by comparing to a substitute population to represent the counterfactual comparison. Since only people exposed to the causal factor can have risk attributable to it, attributable risk in the population will reflect the fact that not everyone in the population is exposed,. If, as is usually the case, some risk for the disease exists even in the absence of the causal factor, then the amount of risk attributable to the factor is the difference between the risk in people who are exposed and that “background risk”. So the “attributable risk” for a factor is the: 1. difference in risk or incidence in exposed and unexposed people or 2. difference in risk or incidence in the total population and unexposed people
  22. As always, an amount of risk can be expressed as an absolute value or relative to some risk of interest. For example, we can speak of the amount of risk attributable to smoking or the proportion of risk that is attributable. Attributable risk can be presented as: 1. an “absolute” number, e.g., “80,000, or 20 per 100 cases/year of stroke are attributable to smoking” 2. a “relative” number, e.g., “20% of stroke cases are attributable to smoking”. By way of analogy, suppose you work two part-time jobs and receive an increase in pay from one of them. You might think about the increase as the additional amount of money you will receive (e.g., another $50/week), or as a percentage increase in your wage (e.g., a 10% increase), or a percentage increase in your total income (e.g., a 5% increase). Each expression is a legitimate way of quantifying the increase, and each expression answers a different implicit question.
  23. Since the algebra for the relative measures of attributable risk can be confusing to people who are not used to working with it, it is often easier to think in terms of the proportion or percentage of caseload, rather than of risk. Suppose that there are n1 people exposed to the causal factor and n0 people who are not exposed. Suppose that the disease incidence is R1 in people exposed to the factor and R0 in people who are not exposed.
  24. Then in the above graph, the rectangle in the lower left shows the caseload that would be expected in the substitute population, the n0 unexposed people: R0n0, the incidence times the number of people, or incidence rate times person-years. The taller rectangle, on the right, shows the caseload expected among the n1 exposed people. If the exposure had no effect at all (or no one were exposed), we would expect the incidence among the n1 exposed people to be the same as that in the substitute population, or R0.
  25. So if the exposure were absent or innocuous, we would expect the caseload in the exposed to be R0 n1, rather than R1n1 cases. Thus, the caseload above the line at R0 is “attributable caseload”. It represents the caseload “attributable” to the exposure in that they would not be expected if the exposure were innocuous. If we desire to estimate attributable risk as a proportion, then we simply divide the number of attributable cases, (R1 – R0) n1, by all exposed cases, I1n1 (for attributable risk among those exposed), or we can divide those same attributable cases by all cases [R0n0 + R1n1] (for attributable risk in the population as a whole).
  26. Now, for our main course, let’s investigate the case-control study design.
  27. The conceptualization of case-control studies has evolved more than most during the past decades. The traditional perspective is based on the intuitive idea that if we compare people who develop a disease to people who do not, then the differences between them should reveal what factors give rise to the disease. The non-cases are called “controls” in a somewhat faulty analogy to controls in an experiment. The basic idea of comparing cases and non-cases to identify differences in exposures or characteristics is fine. However, it turns out to be much more useful for purposes of quantifying risk and understanding the processes at work to regard the case-control design as an efficient sampling method for studying a cohort. In the traditional view, the controls are intended to be “comparable” to the cases except for the exposure under study. However, this concept can readily confuse. In the modern conceptualization, the controls provide a “window” into the study base, that is, a window into the population from which the cases arise.
  28. This diagram shows an iceberg with two peaks, one for cases and one for controls, and a ship, which represents the investigator in danger of foundering on a part of the iceberg that is under water. The diagram illustrates that the simplistic concept of comparing cases and controls can cause difficulty, because most of the population is unseen.
  29. Here is the population at risk in which cases can develop. There are 200 women, men, and children, 25 in each row.
  30. Here is our population of little people, in week 1: Suppose that each circle indicates the occurrence of a case. These circles are red in the original slide.
  31. In the next week (week 2), three new cases have occurred. The cases that occurred previously are indicated by gray circles.
  32. Week 3 – two new cases (in red), and now 5 previous cases (in gray).
  33. So, what has been the rate of occurrence of cases over the three weeks we have just observed? We answer this question by calculating incidence rate. The actual incidence may be fluctuating from day to day, but we are interested in calculating an average for the entire 3-week interval. So the slide, then, has the formula for incidence rate, Number of new cases IR = ––––––––––––––––––– Population time
  34. The incidence rate will be the number of newly-occurring cases, of which there were 7, divided by the amount of population time at risk. How do we estimate the population time at risk?
  35. There were 200 people followed for 3 weeks, so the amount of population-time would be a maximum of 600 person-weeks. However, since we are assuming that once someone becomes a case s/he is no longer at risk to develop the disease again (or equivalently, we are studying first occurrences for each individual), then people who became cases were at risk only until they developed the disease. The 2 people who became cases in week one were not at risk during weeks two or three; the 3 people who became cases during week two were at risk for all of week one but not at all during week three, and so on. Only 193 people were at risk for the entire three weeks. So we had 2 people who became cases in 1st week, 3 people who became cases in 2nd week, 2 people who became cases in 3rd week, and 193 people at risk for 3 weeks.
  36. In the absence of knowledge about the actual time of onset, we usually adopt the conventional practice of assuming that cases developed at the midpoint of the interval in which they were first observed. Under that assumption, the 2 people who became cases during the first week were each at risk for a half-week, so that together they contributed a total of 1 person-week. The 3 people who became cases in the second week were at risk for the entire first week (3 x 1 week = 3 person-weeks) and, we estimate, half of the second week (3 x 0.5 weeks = 1.5 person-weeks), for a total of 4.5 person-weeks. The 2 people who became cases in the third week were at risk for 2.5 weeks each, or a total of 5.0 person-weeks.
  37. So together, the 7 cases were at risk for a total of 10.5 person-weeks, and the 193 people who did not develop the disease were at risk for a total of 579.0 person-weeks. Adding up the population time gives us a total of 589.5 person-weeks for the entire population during the three weeks. Incidentally, we could have obtained the same result by taking the total population-time if no one had developed the disease (600 person-weeks) and subtracting the time that the people who developed the disease were not at risk. There were 7 cases, and if they occurred evenly during the period, as they did, then they were not at risk for an average of 7 × 3 weeks / 2 = 10.5 person-weeks. 600 – 10.5 = 589.5 person-weeks.
  38. The average incidence rate over the 3 week interval is therefore 7 new cases divided by 589.5 person-weeks = 0.0119 cases / person-week, or equivalently, 11.9 cases per 1,000 person-weeks. This is our estimate of the average incidence rate (incidence density) in this population of 200 followed for three weeks.
  39. The incidence rate tells us how fast cases were occurring. We may also (or instead) be interested in knowing how far the disease has penetrated the population. Cumulative incidence is the proportion of the population at risk that developed the disease during a specified time interval. Incidence rate and cumulative incidence are complementary perspectives on the extent of disease occurrence. If the risk period has not ended, then the incidence rate lets us estimate how many more cases will develop in the future. If the risk period has ended at the end of 3 weeks, then CI gives us a “bottom line” for the amount of disease that has occurred.
  40. CI is even easier to compute than IR. There were 7 new cases that occurred in a population of 200 at risk, for a CI of 0.035, or 35 cases per 1,000 population.
  41. The foregoing has largely been a review of the concepts introduced during the lecture on incidence and prevalence. However, a key interest of epidemiology is in identifying determinants of disease. To find which factors are related to the occurrence of disease we generally compare the incidence of disease across different groups in the population. So, for example, if we have a group of people who are exposed to some factor, then we will want to estimate the incidence in that group. Here we have an exposed group of 75 people, in the top three rows of our population at risk. In this first week of follow-up, one new case has occurred.
  42. In week 2, two more new cases have occurred in the exposed group.
  43. And in week 3, the fourth case has occurred.
  44. In order to compare people with and without the exposure, we also need to follow-up a group of people who are not unexposed to the factor. In week 1 we see that a new case has also occurred in this unexposed group, represented by the bottom 5 rows of our population at risk.
  45. In week 2, a second new case has occurred in the unexposed group.
  46. And in week 3, a third case has occurred.
  47. In actual practice, we would usually be following both groups at the same time. So here is our population of 200, in which the top 3 rows (75 people) are exposed (pink color) and the bottom 5 rows (125 people) are unexposed (blue). As before, we see that one new case has occurred in each subgroup. Let’s review the three weeks follow-up in the entire population, and try to keep it in our minds during the rest of the lecture.
  48. During week 2, we see the two exposed cases and one unexposed case.
  49. And in week 3, we see the one more exposed case and one more unexposed case.
  50. Is the exposure associated with a higher occurrence of the disease? Yes, that must be the case, since there were more cases in the exposed subgroup despite the fact that it had fewer people. To quantify that association, we need to compare the incidence among the exposed to the incidence among the unexposed. We can do that by comparing incidence rates or incidence proportions. Whether we use incidence rate or incidence proportion or both measures depends upon our specific objective and the nature of the condition, including the length of the period during which people remain at risk. Let’s begin with IR, which we estimate as the number of new cases / population-time.
  51. Consider first the exposed group. There were 75 exposed people at risk at the beginning of the follow-up period. 74 of them were at risk for the entire first week. If we think of the one case that occurred during week 1 as having been at risk for half of the week, then there were a total of 74.5 person-weeks of population-time during week 1. Similarly, if the two people who developed the disease during week 2 can each be regarded as having been at risk for a half-week, then there were 73 person-weeks at risk in week 2: 72 people (75-1-2) who were at risk for the entire 2nd week plus 2 people at risk for half of the 2nd week. Week 3 began with 72 people at risk, but one of them developed the disease, so instead of 72 person-weeks of follow-up there were only 71.5 in week 3. Adding up the person-time gives us a total of 219 person-weeks, for an ID of 0.018 / week or 18 per 1,000 person-weeks.
  52. Now the unexposed group – during the first week there were 125 people at risk, less a half-person-week for the person who became a case. During the 2nd week, 124 people were at risk at the start of the week but one remained at risk for only half of the week. During the third week 123 people start but one contributes only a half-week. So the total unexposed person-time is 370.5 person-weeks, and the ID among the unexposed is 0.008 / week = 8 per 1,000 person-weeks.
  53. Graphing these two rates clearly shows that the incidence rate is substantially greater among the exposed than among the unexposed.
  54. We can quantify the size of the difference in incidence rates by subtracting the rate in the unexposed from the rate in the exposed. We can call this difference the “incidence density difference” (IDD) or the “incidence rate difference” (IRD). In this case it equals (0.018 – 0.008) = 0.010 / week or 10 per 1,000 person-weeks. Note that just as the incidence rates should be expressed with their units, so should the incidence rate difference. How might we state this difference in words?
  55. The easiest rendition is simply to translate the subtraction into words, and say, “The rate in the exposed was 0.010 / week greater than the rate in the unexposed.”
  56. We can also express the incidence rate difference relative to the size of the incidence rate in the unexposed. So we have (0.018 – 0.008) / 0.008 = 2.25 – 1 = 1.25. Again, we should consider how to state this result in words.
  57. We can state the relative difference as, “The rate in the exposed was 125% greater than the rate in the unexposed.”
  58. Another way of expressing the incidence in the exposed relative to the incidence in the unexposed is by taking the ratio of the former to the latter, giving us an incidence rate ratio (IRR) or incidence density ratio (IDR). [Aside: These two terms, incidence rate and incidence density, are synonymous. The purpose of using both is to help you to become familiar with both terms and to remind you that they are synonyms.] Again, we should consider how to express the result of this calculation in words.
  59. We can say, simply, that “the rate in the exposed was 2.25 times the rate in the unexposed.” Many people will say “2.25 times greater”, but it is better to avoid such phraseology, since it can introduce ambiguity. For example, 2.25 times “greater” sounds like a 225% increase, but we just saw the relative increase was 125%.
  60. You are probably wondering what happened to case-control studies? Wasn’t this supposed to be a lecture on case-control studies? Funny you should ask. I was just getting around to that. The purpose of considering incidence in exposed and unexposed, and comparisons of incidence, is that we are going to analyze case-control studies as windows into incidence in cohorts. So it is helpful to analyze the underlying process of incidence in cohorts, and how to compare incidences, before looking through the window. We are going to see how case-control studies can enable us to estimate the IRR and CIR with something called the odds ratio.
  61. An OR is a ratio of odds. Odds are ratios of probabilities. Risk is a probability – usually the probability of some adverse outcome. So a ratio of risks is a “risk odds”. Most often, the ratio is formed by taking a probability or risk and dividing by its inverse, which is the risk subtracted from 1.0 As can be seen from the table on the slide, when the risk is small, the risk odds are almost identical to the risk, which makes sense, because we are dividing by (1 – risk), which for small risks is like dividing by 1.0 So a risk of 0.050 corresponds to an odds of 0.053. As risk increases, however, (1 – risk) becomes smaller, so the odds becomes greater than the corresponding risk, eventually quite a bit greater. A risk of 0.80 corresponds to an odds of 4.0 Although we do not tend to use them in epidemiology, you may be more familiar with what are known as “betting odds”. If the probability of winning is 0.25 and probability of losing is therefore 0.75, for a fair bet you would want to be able to win 3 times the amount that you are exposed to losing. So a loss probability of 0.75 translates into betting odds of 0.75/0.25 = 3. A fair bet at those odds means that for every dollar you stand to lose, you stand to gain 3 dollars. If you bet at these odds and probabilities, in the long run you should come out even.
  62. This graph shows the relation between the odds, on the vertical axis, and probability, on the horizontal axis, when probability is small – less than 10%, for example. As you can see, the odds are nearly identical to the probability.
  63. By contrast, for larger probabilities the numerical value of the odds exceeds the corresponding probability, until for probabilities close to 100% the odds increase without limit.
  64. Probabilities are estimated with proportions, and any ratio of two natural numbers – the numbers that we use for counting – can be converted to an odds by simply dividing by the sum of the numbers. For example, if we have 20 exposed persons and 30 unexposed persons – 50 persons in all – then there are 20/50, or 40%, exposed persons and 30/50, or 60%, unexposed persons. If we take the ratio 20/30, that is equivalent to 40%/60%, which we see is an odds – the odds of exposure in this group of 50 persons.
  65. So now you will see what this has all been leading up to. When we compare incidences between the exposed and unexposed groups in order to identify risk factors – characteristics or exposures associated with higher incidence rates – we frequently wish to estimate the incidence rate ratio. And, interestingly, the incidence rate ratio can be regarded as a ratio of odds. The reason that is interesting is that, as we shall see, we can estimate odds ratios from case-control data.
  66. Recall that the incidence rate ratio is the ratio of incidence density in the exposed to incidence density in the unexposed.
  67. Each of these incidence rates is the number of new cases in the subgroup divided by the amount of population-time in that subgroup. So, the IRR has as a numerator, the number of exposed cases divided by the exposed population-time, and as a denominator, the number of unexposed cases divided by unexposed population-time.
  68. It is a simple algebraic manipulation to make the numerator a ratio of exposed to unexposed cases …
  69. … and the denominator a ratio of exposed to unexposed population-time.
  70. The ratio of exposed to unexposed cases can be regarded as the odds of exposure (the “exposure odds”) in the cases. These exposure odds are the odds of selecting an exposed case in a random pick from among all of the cases.
  71. Similarly, the ratio of exposed to unexposed population-time can be regarded as an “exposure odds” of population-time. The exposure odds in population-time are the odds that a randomly selected person-week is an exposed one.
  72. So now let’s compute the incidence rate ratio by using our knowledge of odds. Here are the cases that occurred during the 3-week interval we observed earlier in the lecture.
  73. Here are the results from our incidence rate calculations earlier in the lecture. If you are seeing this in color, the 7 cases (4 plus 3) are shown in red, since we will use them to estimate the exposure odds in the cases.
  74. So the exposure odds in the cases are simply 4/3, or 1.33.
  75. The person-time, now shown in red, will be used to estimate the exposure odds in the population-time.
  76. The exposure odds are simply the ratio of exposed to unexposed population-time.
  77. So we can calculate the incidence rate ratio associated with exposure as a ratio of odds, the ratio of the exposure odds in cases to the exposure odds in population-time. Reassuringly, it is the same as the value we came up with earlier.
  78. Of course, it’s no big feat to calculate the same number by using an algebraically-equivalent formula. But the new formulation opens up the possibility of estimating the incidence rate ratio without having to follow an entire cohort – if we can come up with a way to estimate the exposure odds in the population. We can often estimate the exposure odds in cases, since cases typically come to the attention of the health care system or a surveillance system. Also, the number of cases is usually relatively modest. But if the condition occurs at a low rate, then enrolling a cohort means examining a large number of people who will not become cases – tens, hundreds, thousands, or even more non-cases for each case. If we can estimate the odds of exposure from a sample of the people who do not become cases, then we can meet our objective with much less time, effort, and expense.
  79. Here is our familiar population again, shown in week 1, with the two new cases. We are going to take a sample of the “risk set”, the people at risk during each of the three weeks. The method we are using is called “density sampling” or “risk set sampling”. For this method we choose a number of non-cases that corresponds to the number of cases that occurred during the same week. The number does not have to be identical, so here we are taking about two controls for each case. Here is the week 1 sample, indicated with the boxes around the people “randomly” selected for the sample. Since there were two cases, we should draw 4 controls to achieve the 2:1 ratio we seek. The extra control in this instance has been taken to make the arithmetic come out better – a little poetic license, if you will.
  80. Here is the week 2 sample, again indicated with boxes. Note that the week 2 cases are shown here in red, as earlier. There were 3 new cases in week two, so we have selected 6 controls for our 2:1 ratio.
  81. And finally, the week 3 sample. Note that these samples are being taken from everyone who is at risk of the disease at the time of sampling. In principle, a control selected in week 1 could become a case in week 2 or week 3. Once again, I selected an extra control to make the arithmetic work better. (If the sample and population were larger, I would not need to resort to this sleight of hand.)
  82. Now, can we estimate the incidence density ratio using our case-control data, in which the “density controls” serve to provide an estimate of exposure odds in population-time?
  83. Here is the incidence density ratio formula, with exposure odds in the controls substituted for the exposure odds in population-time. This formula would normally be referred to as an “odds ratio”, or OR, since it is a ratio of odds.
  84. We saw previously that the exposure odds in the cases were 1.33, so I have substituted that value here. Our “random” sample of 16 controls (5 in week 1, 6 in week 2, and 5 in week 3) had 6 people who were exposed, so the exposure odds are 6 exposed / 10 unexposed = 6 / 10 = 0.60. So the odds ratio is 2.22. How does this compare with the value we calculated in the cohort? Recall that there were 219 person-weeks in the exposed population-time and 370.5 person-weeks of unexposed population-time, for exposure odds of 0.59 and an OR of 2.25. So we have come very close with our sample of 16 controls.
  85. This slide shows (1) how we would summarize the data in a table and (2) the formula we would use for the odds ratio. The typical 2 x 2 table shows disease status along one dimension and exposure status along the other dimension. Please note that there is no accepted convention for whether disease status should be shown across the columns or across the rows (my own Evolving Text has disease status across the rows in all of the 2 x 2 tables, since that was the style in the textbook from which I learned advanced epidemiology (Kleinbaum, Kupper, and Morgenstern). When the authors were writing that text, originally David Kleinbaum created his tables with disease across the top and Larry Kupper drew his tables with disease along the side. After each had written several chapters, they negotiated and ended up following Larry’s style. That won’t be surprising to those of you who know Larry. One nice feature of the odds ratio is that the formula can be expressed as ad/bc, which is invariant for either tabular orientation, as long as cases and exposed are each listed before noncases and unexposed, respectively.
  86. Here is the 2 x 2 table and OR calculation with the numbers from our example.
  87. What if our interest is in cumulative incidence and the cumulative incidence ratio instead of in incidence density and incidence density ratio? Let us see how we can estimate CIR from case-control data.
  88. We begin with the population at risk of 200 little people.
  89. Skipping forward to week 3, we recall that there were 4 exposed cases and 3 unexposed cases, leaving 71 exposed non-cases and 122 unexposed noncases.
  90. The 3-week cumulative incidence in the exposed was 4/75, or 0.053 (53 per 1,000).
  91. The 3-week cumulative incidence in the unexposed was 3/125, or 0.024 (24 per 1,000).
  92. We don’t really need a graph to see that the cumulative incidence in the exposed was about double that in the unexposed.
  93. If we want to quantify the strength of the association, we can estimate a 3-week cumulative incidence difference (CID). So, 0.053 – 0.024 = 0.029. CI has no units, so neither does CID.
  94. And we can state it in words: “The 3-week cumulative incidence in the exposed was 0.029 greater than in the unexposed.”
  95. We can express this difference as a relative measure, generally relative to the cumulative incidence in the unexposed. So, (0.053 – 0.024) / 0.024 = 0.029 / 0.024 = 1.22.
  96. Stating that in words . . . “The 3-week CI in the exposed was 122% greater than in the unexposed.”
  97. Most often we simply take the ratio of the incidence proportion in the exposed to the incidence proportion in the unexposed. The 3-week cumulative incidence ratio (CIR) = (0.053 / 0.024) = 2.22
  98. We can say that as, “The 3-week CI in the exposed was 2.2 times that in the unexposed.” Again, when we translate that value into words it is better to avoid the phrase “times greater”, since it introduces ambiguity.
  99. Cumulative incidence ratio: CI1 Exposed cases / Exp PAR CIR = –––– = –––––––––––––––––––––––––– CI0 Unexposed cases / Unexp PAR can now be expressed as a ratio of odds of exposure in cases to odds of exposure in the population at risk.
  100. The cases for the CIR are just the same as the cases for the IDR, so we still have the exposure odds in cases for the numerator, and now we divide by the denominator, which is the odds of exposure for the population at risk.
  101. The denominators for cumulative incidence are population at risk at the start of the follow-up period, rather than population-time during the period. So for the CIR, the denominator exposure odds are the exposure odds in the population at risk at baseline. That is, therefore, the number of exposed people in the population at risk divided by the number of unexposed people in the population at risk.
  102. As expected, the CIR can be expressed as a ratio of exposure odds in cases to exposure odds in the population at risk.
  103. Since we are using the same cases as for the IDR, the exposure odds in cases are identical to before, 4/3 = 1.33.
  104. Here is the population at risk at the beginning of the period, once again – 200 people, with the top three rows exposed and the bottom five rows unexposed.
  105. The exposure odds in the population at risk are slightly different from the exposure odds for population-time, since the starting population at risk is unaffected by the subsequent development of cases. So we have three rows of exposed or 75 little people and five rows of unexposed, or 125 little people, for an exposure odds of 75 / 125, or 0.60, which is a slightly different number from the odds of exposure for person-time, since we do not reduce the population at risk for the occurrence of cases.
  106. Calculating our 3-week cumulative incidence ratio as a ratio of odds naturally gives us the same value that we obtained from the ratio of two cumulative incidences. (Although this CIR also equals the value of the OR computed with density controls, that happens to be just a coincidence.)
  107. The upshot of this is that if we can estimate the exposure odds in the population at risk, then we may not need to analyze the entire cohort in order to estimate the CIR. Estimating the CIR by using a sample of the baseline population at risk is called a “case-cohort” or “case-base” design (the word “base” refers to the “study base”, which is the population from which cases arise). Even if one has recruited and followed a cohort, a case-cohort analysis can be very advantageous in situations where an expensive analysis of stored specimens is needed to determine exposure status. For example, a cohort of 4,000 people may yield 200 cases. Rather than analyze serum specimens for all 4,000 people, a powerful study can be carried out by analyzing the specimens for the 200 cases and for a sample of, say, 800 people from the original cohort. Besides saving a great deal of resources, having to analyze only 1,000 specimens instead of 4,000, this design preserves more specimen for analyses of other exposures at a later time.
  108. So here we have our sample from the population at risk, before the cases occurred. Again, the boxes indicate people selected into the sample. Note that as with density sampling, some of these people may in fact develop the disease and be counted also as cases.
  109. We can calculate the odds of exposure in this sample (traditionally referred to as “controls”, even though they are not like the controls in an experiment) and we can use the result to estimate the exposure odds in the population at risk. As before, they equal 0.60.
  110. So the 3-week CIR estimated from the ratio of exposure odds in cases to exposures odds in controls is 1.33/0.6 = 2.22, identical to what we found by taking the ratio of cumulative incidences. Of course, in real life we would expect some difference, due to sampling variability.
  111. Now, it may be difficult to sample the population at risk, since we may not be able to identify them, and we may not be able to know their exposure status at the beginning of the follow-up period. In this case we can draw our controls from the noncases at the end of the follow-up period.
  112. Here is the end of the follow-up period. There were 4 exposed cases, leaving 71 exposed noncases. There were 3 unexposed cases, leaving 122 unexposed noncases.
  113. The exposure odds among noncases, then, is 71 / 122 = 0.58, which as we would expect differs slightly from the two population exposure odds we calculated before.
  114. The odds ratio formed by using the exposure odds in noncases will always be slightly farther from 1.0 than that obtained by using the exposure odds from the original population at risk. So the 1.33 exposure odds in cases divided by the 0.58 exposure odds in the population of noncases, which equals 2.29, is slightly farther from 1.0 than was the cumulative incidence ratio when we estimated it from the cohort. Of course, if the disease is rare, then all of these ratios will be approximately the same, which is why it is stated that the odds ratio from a case-control study estimates the cumulative incidence ratio when the disease is rare.
  115. So again, if we obtain a sample of controls from among the non-cases (these are sometimes called “cumulative controls” or “survivor controls”), we might obtain 5 exposed controls and 9 unexposed controls.
  116. So the exposure odds in the “cumulative” controls are the number of exposed noncases, or 5, divided by the number of unexposed noncases, or 9, and I’m saying that that equals 0.58; it actually equals 0.555, but if I had a large enough sample and a larger population, I would get 0.58, on the average. So the exposure odds for the cumulative controls are about 0.58. (Please forgive my fudging here, but you didn’t really want me to use a larger sample size, did you?)
  117. Thanks to the fudging, the OR estimate here, 1.33 / 0.58 = 2.29, is identical to that obtained by using the exposure odds for all noncases. Again, it is slightly larger than the CIR.
  118. We have now seen how the case-control design provides an efficient sampling technique for studying the occurrence of disease in an underlying cohort. The examples considered all make use of incident (newly-occurring) cases. That is a key consideration. One can carry out a case-control study using prevalent (i.e., existing) cases, but such a study raises other issues since prevalent cases may not be representative of all newly-occurring cases (if, for example, characteristics related to risk are also related to prognosis). There are some times when we may prefer to use prevalent cases, but most often incident cases are preferred. The validity of the case-control design depends on, among other things, whether the controls do indeed provide an unbiased estimate of the population from which the cases arose (called the “study base”). So when we look through the window, it is important that window provide an unobstructed and undistorted view. Though a powerful and efficient methodology, case-control studies are susceptible to various sources of bias, related both to the selection of cases and controls and also to the measurement of exposures in cases and controls. Some of these sources of bias are present in cohort studies as well, but they tend to be more problematic in case-control studies. For example, ascertainment of exposure in a cohort is almost always equivalent for cases and non-cases, because the disease has not occurred at the time of exposure measurement. In contrast, in a typical case-control study, measurement of exposure takes place after disease has occurred. The latter situation creates numerous opportunities for the measurement of exposure to differ for people who developed the disease and people who did not, which, of course, will readily produce spurious results.
  119. And, if you didn’t like the instructions on my exam, here are some good ones from an Adobe Font Pack for Windows, courtesy of PC Magazine: “Notice to user: By breaking the seal of this envelope, you accept the terms of the enclosed license agreement.”